|
Therapie
invasiver Pilzinfektionen
(aus
ZCT 1-2007)
Literaturzitate
1. FLÜCKIGER, U.
et al.
Treatment options of invasive fungal infections in adults.
Swiss
Med Wkly
2006;136: 447 - 463
2. SPANAKIS, E.K.
et al.
New
agents for the treatment of fungal infections: clinical efficacy and
gaps in coverage.
Clin
Infect Dis
2006; 43: 1060 - 1068
3. MEERSSEMAN, W.
et al.
Invasive aspergillosis in critically ill patients without malignancy.
Am
J Respir Crit
Care Med 2004; 170: 621 - 625
4. HACHEM, R.Y. et al.
Aspergillus
terreus: an emerging amphotericin B-resistant opportunistic mold in
patients with hematologic malignancies.
Cancer
2004; 101: 1594
- 1600
5. CORNELY, O.A.
Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive
Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial
of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).
Blood
2005; 106:
900a (Abstract)
6. CAILLOT, D. et al.
Intravenous itraconazole followed by oral itraconazole
in the treatment of invasive pulmonary aspergillosis in patients with
hematologic malignancies, chronic granulomatous disease, or AIDS.
Clin
Inf Dis 2001; 33: e83
- e90
7. HERBRECHT, R.
et al.
Voriconazole versus amphotericin B for primary therapy of invasive
aspergillosis.
N
Engl J Med 2002;
347: 408 - 415
8. ULLMANN, A.J. et al.
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host
disease.
N
Engl J Med 2007;
356: 335 - 347
9. MAERTENS, J. et
al.
Efficacy and safety of caspofungin for treatment of
invasive aspergillosis in patients refractory to or intolerant of
conventional antifungal therapy.
Clin Inf Dis
2004; 39: 1563 - 1571
10. MAERTENS, J. et al.
Multicenter, noncomparative study of caspofungin in
combination with other antifungals as salvage therapy in adults with
invasive aspergillosis.
Cancer
2006; 107: 2888
- 2897
11. WINSTON, D.J.
et al.
A multicenter, randomized trial of fluconazole versus
amphotericin B for empiric antifungal therapy of febrile neutropenic
patients with cancer.
Am
J Med 2000;
108: 282 - 289
12. BOOGAERTS, M. et al.
Intravenous and oral itraconazole versus intravenous
amphotericin B deoxycholate as empirical antifungal therapy for
persistent fever in neutropenic patients with cancer who are receiving
broad-spectrum antibacterial therapy. A randomized, controlled trial.
Ann
Intern Med 2001; 135: 412 - 422
13. WALSH, T.J. et al.
Voriconazole compared with liposomal amphotericin B for
empirical antifungal therapy in patients with neutropenia and
persistent fever.
N
Engl J Med 2002; 346: 225 - 234
14. WALSH, T.J. et
al.
Caspofungin versus liposomal amphotericin B for empirical antifungal
therapy in patients with persistent fever and neutropenia.
N Engl J Med 2004; 351: 1391 -
1402
|
